exendin based glp 1 PDB-101: Molecule of the Month: GLP-1 Receptor Agonists In Vitro Characterization of Agonist
Description
In an investigative report in partnership with KFF Health News, NBC News Anne Thompson reports on the growing cases of overdoses involving GLP-1 weight loss drugs.
GLP-1 dry mouth affects many semaglutide and tirzepatide users
mean follow-up: 6.54 years)
GLP-1 receptor agonists like semaglutide have demonstrated effects on cholesterol and triglyceride profiles beyond weight loss
This performance reflects unprecedented demand despite earlier supply constraints and sets the stage for pricing and reimbursement debates as the market matures
